Allosteric communication between protomers of dopamine Class A GPCR dimers modulates activation
暂无分享,去创建一个
Irina S. Moreira | Jonathan A. Javitch | Harel Weinstein | H. Weinstein | I. Moreira | J. Javitch | Yang Han | E. Urizar | Eneko Urizar | Yang Han | Eneko Urizar
[1] J. Ballesteros,et al. [19] Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors , 1995 .
[2] J. Pin,et al. G Protein Activation by the Leukotriene B4 Receptor Dimer , 2008, Journal of Biological Chemistry.
[3] H. Hamm,et al. The 2.0 Å crystal structure of a heterotrimeric G protein , 1996, Nature.
[4] P. Molinari,et al. Promiscuous Coupling at Receptor-Gα Fusion Proteins , 2003, The Journal of Biological Chemistry.
[5] A M J J Bonvin,et al. Data‐driven docking: HADDOCK's adventures in CAPRI , 2005, Proteins.
[6] S. Costagliola,et al. Structure-function relationships of two loss-of-function mutations of the thyrotropin receptor gene. , 1999, Thyroid : official journal of the American Thyroid Association.
[7] Marta Filizola,et al. Modeling activated states of GPCRs: the rhodopsin template , 2007, J. Comput. Aided Mol. Des..
[8] L. Prézeau,et al. Closed state of both binding domains of homodimeric mGlu receptors is required for full activity , 2004, Nature Structural &Molecular Biology.
[9] Ann Allergy,et al. O R I G I N a L a R T I C L E S , 2022 .
[10] A. Sali,et al. Comparative protein structure modeling of genes and genomes. , 2000, Annual review of biophysics and biomolecular structure.
[11] Marta Filizola,et al. Dopamine D2 receptors form higher order oligomers at physiological expression levels , 2008, The EMBO journal.
[12] H G Khorana,et al. Structure and function in rhodopsin. Single cysteine substitution mutants in the cytoplasmic interhelical E-F loop region show position-specific effects in transducin activation. , 1996, Biochemistry.
[13] G. Milligan,et al. Functional Complementation and the Analysis of Opioid Receptor Homodimerization , 2005, Molecular Pharmacology.
[14] Graeme Milligan,et al. Dimers of Class A G Protein-coupled Receptors Function via Agonist-mediated Trans-activation of Associated G Proteins* , 2003, Journal of Biological Chemistry.
[15] G. Marshall,et al. Rhodopsin-transducin interface: studies with conformationally constrained peptides. , 2001, Biophysical journal.
[16] Graeme Milligan,et al. Agonist occupancy of a single monomeric element is sufficient to cause internalization of the dimeric beta2-adrenoceptor. , 2007, Cellular signalling.
[17] M. Moussaif,et al. Rhodopsin Determinants for Transducin Activation , 2003, Journal of Biological Chemistry.
[18] G. Milligan,et al. CXCR2 chemokine receptor antagonism enhances DOP opioid receptor function via allosteric regulation of the CXCR2–DOP receptor heterodimer , 2008, The Biochemical journal.
[19] A. Bax,et al. Structure and orientation of a G protein fragment in the receptor bound state from residual dipolar couplings. , 2002, Journal of molecular biology.
[20] Leonardo Pardo,et al. An Activation Switch in the Rhodopsin Family of G Protein-coupled Receptors , 2005, Journal of Biological Chemistry.
[21] L. Prézeau,et al. Evolution, structure, and activation mechanism of family 3/C G-protein-coupled receptors. , 2003, Pharmacology & therapeutics.
[22] J. Banères,et al. Cooperative Conformational Changes in a G-protein-coupled Receptor Dimer, the Leukotriene B4 Receptor BLT1* , 2004, Journal of Biological Chemistry.
[23] Marta Filizola,et al. Crosstalk in G protein-coupled receptors: changes at the transmembrane homodimer interface determine activation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[24] S. Rees,et al. A cysteine-3 to serine mutation of the G-protein Gi1 alpha abrogates functional activation by the alpha 2A-adrenoceptor but not interactions with the beta gamma complex. , 1997, Biochemistry.
[25] H Weinstein,et al. Functional role of the spatial proximity of Asp114(2.50) in TMH 2 and Asn332(7.49) in TMH 7 of the μ opioid receptor , 1999, FEBS letters.
[26] J. Ballesteros,et al. The first transmembrane segment of the dopamine D2 receptor: accessibility in the binding-site crevice and position in the transmembrane bundle. , 2000, Biochemistry.
[27] M. A. Downs,et al. Rhodopsin-interacting surface of the transducin γ subunit , 2006 .
[28] C. Strader,et al. Mutations that uncouple the beta-adrenergic receptor from Gs and increase agonist affinity. , 1987, The Journal of biological chemistry.
[29] J. Pin,et al. Asymmetric conformational changes in a GPCR dimer controlled by G‐proteins , 2006, The EMBO journal.
[30] L. Prézeau,et al. Evidence for a single heptahelical domain being turned on upon activation of a dimeric GPCR , 2005, The EMBO journal.
[31] Holger Gohlke,et al. The Amber biomolecular simulation programs , 2005, J. Comput. Chem..
[32] B. O'dowd,et al. Oligomerization of mu- and delta-opioid receptors. Generation of novel functional properties. , 2000, The Journal of biological chemistry.
[33] H Weinstein,et al. The fourth transmembrane segment of the dopamine D2 receptor: accessibility in the binding-site crevice and position in the transmembrane bundle. , 2000, Biochemistry.
[34] R Seifert,et al. Restricting the mobility of Gs alpha: impact on receptor and effector coupling. , 1999, Biochemistry.
[35] E. Weiss,et al. The Effect of Carboxyl-terminal Mutagenesis of G on Rhodopsin and Guanine Nucleotide Binding (*) , 1995, The Journal of Biological Chemistry.
[36] D. Farrens,et al. Rhodopsin Activation Exposes a Key Hydrophobic Binding Site for the Transducin α-Subunit C Terminus* , 2004, Journal of Biological Chemistry.
[37] K. Neve,et al. Modeling and mutational analysis of a putative sodium-binding pocket on the dopamine D2 receptor. , 2001, Molecular pharmacology.
[38] B. Conklin,et al. Substitution of three amino acids switches receptor specificity of Gq alpha to that of Gi alpha. , 1993, Nature.
[39] R Marsault,et al. Transfected Aequorin in the Measurement of Cytosolic Ca2+ Concentration ([Ca2+]c) , 1995, The Journal of Biological Chemistry.
[40] T. Sakmar,et al. The Amino Terminus of the Fourth Cytoplasmic Loop of Rhodopsin Modulates Rhodopsin-Transducin Interaction* , 2000, The Journal of Biological Chemistry.
[41] Tullio Pozzan,et al. Rapid changes of mitochondrial Ca2+ revealed by specifically targeted recombinant aequorin , 1992, Nature.
[42] H. Bourne,et al. A mutation that prevents GTP-dependent activation of the α chain of Gs , 1988, Nature.
[43] M. Parmentier,et al. Allosteric Modulation of Binding Properties between Units of Chemokine Receptor Homo- and Hetero-Oligomers , 2006, Molecular Pharmacology.
[44] Richard N. Zare,et al. A monomeric G protein-coupled receptor isolated in a high-density lipoprotein particle efficiently activates its G protein , 2007, Proceedings of the National Academy of Sciences.
[45] J. Ballesteros,et al. Dopamine D4/D2 receptor selectivity is determined by A divergent aromatic microdomain contained within the second, third, and seventh membrane-spanning segments. , 1999, Molecular pharmacology.
[46] B. Kobilka,et al. GPCR-Galpha fusion proteins: molecular analysis of receptor-G-protein coupling. , 1999, Trends in pharmacological sciences.
[47] G Vassart,et al. Extracellular Cysteines of CCR5 Are Required for Chemokine Binding, but Dispensable for HIV-1 Coreceptor Activity* , 1999, The Journal of Biological Chemistry.
[48] B. O'dowd,et al. Dopamine D1 and D2 Receptor Co-activation Generates a Novel Phospholipase C-mediated Calcium Signal* , 2004, Journal of Biological Chemistry.
[49] Restricting mobility of Gsalpha relative to the beta2-adrenoceptor enhances adenylate cyclase activity by reducing Gsalpha GTPase activity. , 1998, The Biochemical journal.
[50] M. Parmentier,et al. Allosteric properties of G protein-coupled receptor oligomers. , 2007, Pharmacology & therapeutics.
[51] W. Sadee,et al. Hydrophobic amino acid in the i2 loop plays a key role in receptor-G protein coupling. , 1993, The Journal of biological chemistry.
[52] H. Khorana,et al. Mapping of contact sites in complex formation between light-activated rhodopsin and transducin by covalent crosslinking: Use of a chemically preactivated reagent , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[53] Rolf Boelens,et al. Information-driven protein–DNA docking using HADDOCK: it is a matter of flexibility , 2006, Nucleic acids research.
[54] Francine Acher,et al. Asymmetric Functioning of Dimeric Metabotropic Glutamate Receptors Disclosed by Positive Allosteric Modulators* , 2005, Journal of Biological Chemistry.
[55] J. Javitch,et al. Residues in the fifth membrane-spanning segment of the dopamine D2 receptor exposed in the binding-site crevice. , 1995, Biochemistry.
[56] N. Artemyev,et al. Rhodopsin Determinants for Transducin Activation: A Gain-of-Function Approach , 2003 .
[57] B. Kobilka,et al. GPCR–Gα fusion proteins: molecular analysis of receptor–G-protein coupling , 1999 .
[58] S. Karnik,et al. Transducin-α C-terminal Peptide Binding Site Consists of C-D and E-F Loops of Rhodopsin* , 1997, The Journal of Biological Chemistry.
[59] B. Conklin,et al. Substitution of three amino acids switches receptor specificity of Gqα to that of Giα , 1993, Nature.
[60] Olivier Lichtarge,et al. Receptor and βγ Binding Sites in the α Subunit of the Retinal G Protein Transducin , 1997, Science.
[61] H. Khorana,et al. Mapping of contact sites in complex formation between transducin and light-activated rhodopsin by covalent crosslinking: Use of a photoactivatable reagent , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[62] Lei Shi,et al. The Fourth Transmembrane Segment Forms the Interface of the Dopamine D2 Receptor Homodimer* , 2003, The Journal of Biological Chemistry.
[63] J. Ballesteros,et al. Activation of the β2-Adrenergic Receptor Involves Disruption of an Ionic Lock between the Cytoplasmic Ends of Transmembrane Segments 3 and 6* , 2001, The Journal of Biological Chemistry.
[64] O. Lichtarge,et al. Receptor and betagamma binding sites in the alpha subunit of the retinal G protein transducin. , 1997, Science.
[65] J. Pin,et al. Activation of a Dimeric Metabotropic Glutamate Receptor by Intersubunit Rearrangement* , 2007, Journal of Biological Chemistry.
[66] K. Lorenz,et al. Conformational cross-talk between alpha2A-adrenergic and mu-opioid receptors controls cell signaling. , 2008, Nature chemical biology.
[67] Michel Bouvier,et al. International Union of Basic and Clinical Pharmacology. LXVII. Recommendations for the Recognition and Nomenclature of G Protein-Coupled Receptor Heteromultimers , 2007, Pharmacological Reviews.
[68] J. Javitch,et al. Mechanisms of inverse agonism of antipsychotic drugs at the D2 dopamine receptor: use of a mutant D2 dopamine receptor that adopts the activated conformation , 2001, Journal of neurochemistry.
[69] P. Henklein,et al. Mutation of the Fourth Cytoplasmic Loop of Rhodopsin Affects Binding of Transducin and Peptides Derived from the Carboxyl-terminal Sequences of Transducin α and γ Subunits* , 2000, The Journal of Biological Chemistry.
[70] H. Khorana,et al. Opsin is present as dimers in COS1 cells: identification of amino acids at the dimeric interface. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[71] Oliver P. Ernst,et al. Crystal structure of opsin in its G-protein-interacting conformation , 2008, Nature.
[72] D. Oprian,et al. Transducin Activation by Nanoscale Lipid Bilayers Containing One and Two Rhodopsins* , 2007, Journal of Biological Chemistry.
[73] P. Conn,et al. Cis- and trans-activation of hormone receptors: the LH receptor. , 2002, Molecular endocrinology.
[74] Arthur Christopoulos,et al. Functional Selectivity and Classical Concepts of Quantitative Pharmacology , 2007, Journal of Pharmacology and Experimental Therapeutics.
[75] R. Shigemoto,et al. GABAB-receptor subtypes assemble into functional heteromeric complexes , 1998, Nature.